Clofibrate and fat embolism: a double-blind trial of the effects of clofibrate on sequelae to injury.
In a double-blind prospective trial clofibrate was found not to influence significantly the clinical and laboratory indices thought to reflect the state of fat embolism in patients with fractures.
D000328:Adult; D000368:Aged; D002986:Clinical Trials as Topic; D002994:Clofibrate / Q000097:blood / Q000627:therapeutic use*; D004620:Embolism, Fat / Q000150:complications / Q000517:prevention & control*; D005223:Fats / Q000652:urine; D005260:Female; D050723:Fractures, Bone / Q000150:complications*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010101:Oxygen Consumption; D010384:Pelvic Bones / Q000293:injuries; D014280:Triglycerides / Q000097:blood
D005223:Fats; D014280:Triglycerides; D002994:Clofibrate